PubMed Health⌕ Search

Biomedical subjects

K J DeBenedictis

Publications and source records attributed to K J DeBenedictis.

2 recordsLinked to original sources

The microbiology "unknown" misadventure.

A 19-year-old nursing student was hospitalized after several days of nausea, vomiting, diarrhea, and fevers. Salmonella paratyphi A was isolated from multiple blood cultures. Because this is an unlikely isolate in the United States, an investigation ensued. Two and a half weeks earlier, the student had been working on a microbiology laboratory exercise "unknown." Both the "unknown" organism and the patient's blood culture isolates were identified as S. paratyphi A, with the same biochemical reactions and antimicrobial susceptibility results. The patient's condition improved with antibiotic therapy, and she was discharged after 9 days in the hospital. Conclusions related to our investigation are as follows: (1) relatively virulent organisms were unnecessary to fulfill the laboratory objectives, (2) pipetting by mouth must never be allowed, (3) proper labeling of specimens is imperative, (4) instructors should have knowledge of laboratory safety regulations, and (5) it is the obligation of laboratory directors and administrators to provide a safe academic environment.

Adult↗

A double-blind study comparing cefonicid with cefazolin as prophylaxis in patients undergoing total hip or knee replacement.

In a randomized double-blind design, cefonicid, an investigational cephalosporin, was compared with cefazolin as prophylaxis in 76 patients undergoing total hip or knee replacement. Risk factors were similar in both groups, and no toxicity was seen with either the control drug, cefazolin, or the test drug, cefonicid. In this small group of patients followed for a short period (four months to one year), no wound sepsis or early or delayed prosthetic sepsis was found, and no superiority of one drug over the other could be demonstrated. Because of the already low incidence of prosthetic infection in patients given appropriate prophylaxis, a larger sample size and a more extended follow-up would be necessary to show increased efficacy of a new compound relative to that of an accepted and proven older drug.

Adult↗